Articles On CogState (ASX:CGS)

ASX recovers to finish a bit less awful than it was at lunchtime, down 0.2% Magnis Energy Technologies climbs 6% on news that Elon wants to Bogart all its battery metals Connexion Telematics’ General Motors contract extension prompts an 80...

The S&P/ASX 200 Index (ASX: XJO) has dropped into the red on Tuesday. In afternoon trade, the benchmark index is down 0.25% to 7,333.1 points. Four ASX shares that are falling more than most today are listed below. Here’s why they a...

Thanks to vaccines and better treatments for COVID-19, much of the developed world seems to have moved on from the pandemic. Even China, which had suffered from brutal zero-virus policies for three years, is starting to relax its stance de...

The Downer EDI Ltd (ASX: DOW) share price is under pressure again on Friday. In morning trade, the engineering and construction company’s shares are down a further 7% to $3.54. This means the Downer share price is now down 26% over the l...

The Downer EDI Ltd (ASX: DOW) share price is plummeting today after the company downgraded its guidance and revealed a historical accounting error with a potential $40 million impact. The engineering and construction company has identified...

The Woodside Energy Group Ltd (ASX: WDS) share price has been a strong performer over the past 12 months. And in November, the S&P/ASX 200 Index (ASX: XJO) oil and gas stock gained another 3.6%. The first part of November saw the Wood...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think th...

If there has been a winner from the global energy shortage, it would have to be oil shares. Energy elites of the S&P/ASX 200 Index (ASX: XJO) have enjoyed enormous profits as conflicts crimp the supply of the commodity. For shareholde...

The Woodside Energy Group Ltd (ASX: WDS) share price is in the red today. Woodside shares are down 2% and currently fetching $35.91 apiece. For perspective, the S&P/ASX 200 Index (ASX: XJO) is sliding 0.56% today. Let’s take a look a...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a strong day and charged notably higher. The benchmark index rose 0.95% to 7,354.4 points. Will the market be able to build on this on Friday and end the week on a high? Here are five...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on form again and on course to record a solid gain. At the time of writing, the benchmark index is up 0.75% to 7,337.6 points. Four ASX shares that have failed to follow the mark...

Fund manager Wilson Asset Management (WAM) has identified two top small-cap ASX shares in one of the portfolios it manages that could be investment ideas. WAM operates several listed investment companies (LICs). Some, like WAM Leaders...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Healthcare is one of those industries that enjoys relatively stable demand through tougher economic times. With consecutive interest rises forcing Australians to close their wallets, this might be a consideration for the coming period. But...

It was another lousy month for the S&P/ASX 200 Index (ASX: XJO) as the benchmark index shed 7.3% to finish at 6,474 points. But as concerns over rising interest rates and inflation linger, it was no surprise to see ASX tech shares at t...

The S&P/ASX All Ordinaries Index (ASX: XAO) had another treacherous month in September as concerns of rising inflation and interest rates continued to rattle the market. The ASX All Ords index shed 7.6% across the month to close out Se...

As nerves mount for players on both NRL Grand Final sides preparing to line up at Staiudm Australia on Sunday night, it’s worth remembering the myriad enterprises that enable sportspeople to leap higher and kick further – while also tending...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is having a day to remember. At the time of writing, the benchmark index is up 1.8% to 6,579.1 points. Four ASX shares that are climbing more than most today are listed below. Here’s...

The Cogstate Limited (ASX: CGS) share price has continued its ascent on Thursday. In morning trade, the neuroscience technology company’s shares are up a further 17% to $2.24. Though, it is worth noting that the Cogstate share price was up...

Nasdaq-listed Biogen says its experimental Alzheimer’s drug study was successful The news sends ASX-listed Cogstate to soar Orthocell could have the first FDA-approved injectable cell therapy in orthopaedics  Big news out of Nasdaq-listed...

ASX 200 down 0.5% Small caps  crash about 1.1% OXR up 50% on some quality HR     And that’s how you say Wednesday was merde in French. Let’s do some good news first. Aussie retail sales climbed for an eighth consecutive month in August,...

The S&P/ASX 200 Index (ASX: XJO) has resumed its downward trend on Wednesday. In afternoon trade, the benchmark index is down 0.8% to 6,442.4 points. Four ASX shares that are not letting that hold them back today are listed below. Here...

The CogState Limited (ASX: CGS) share price is having a sensational day. In morning trade, the neuroscience technology company’s shares were up as much as 61% to $2.26 before being halted. Why is the CogState share price rocketing higher?...

It has been a disappointing year for the CogState Limited (ASX: CGS) share price. Since the start of 2022, the neuroscience technology company’s shares have tumbled 43% to $1.45. Is the CogState share price in the buy zone? One leading b...

The All Ordinaries Index (ASX: XAO) is in the green today, lifting 0.72%, but these shares are defying its gains. They’re each trading lower on the back of their companies’ latest earnings being released. Let’s take a look at how thes...

    Image source: © Terovesalainen | Megapixl.com Image description: Person with mental stress seeking professional help   Highlights Several countries around the globe observe May as the month of Mental Health Awareness Globally...

The healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two million people. Treasurer Josh Frydenberg announced last night that Australia’s health budget will top $132bn in 2022-23, up from $62bn a decade...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200 has fallen by 2.15%. It’s all about earnings today for ASX health stocks. Here’s a highlight of where they stand in the first half.   Round...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar...

Key points The CogState share price fell as low as $1.84 today — 20% down on yesterday’s close The neuroscience technology company released a quarterly update today Clinical sale contracts have increased by 141%, hitting a new record T...

Wall Street loses early gains US stocks sailed in positive territory throughout the day before fading away in the last hour of trading. All three major benchmarks ended the day deep in the red – the S&P 500 by 1.1%, the Dow by 0.89%, an...

The CogState Ltd (ASX: CGS) share price is moving with gusto today following the release of its quarterly cash flow statement. In afternoon trade, shares in the neuroscience technology company are fetching $2.40, up 9.59%. Here’s what th...

ASX shares on the smaller end of town can sometimes feel like a double-edged sword. Their size and growth ambitions can, at times, deliver explosive returns. On the flip side, many small caps are fraught with execution risk and often strug...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

Leading the health stocks today is Nanosonics (ASX:NAN)  up 19.69% after flagging FY21 revenues of $103.1 million, with strong momentum in H2 where revenues came in at $60 million – up 39% from H1. The company installed 3,030 units of its a...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

The Cogstate Limited (ASX: CGS) share price is flying 4.53% high in trade today. Shares in the biotech company have received a boost after releasing a business update earlier today. Here’s what the company announced and why investors are j...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week Healthcare fi...

Wall Street mixed, oil prices volatile The US markets returned from the long weekend Independence Day holiday, and posted mixed results. The Dow Jones fell by 0.60%, S&P 500 was down 0.20%, but the Nasdaq rose by 0.17%. The Pentagon has...

Over the past month, a number of US FDA approvals have moved the share prices of global pharma stocks, including those traded here on the ASX. The biggest FDA announcement during the month came out of US-based Biogen, which received a contr...

Shares in Actinogen Medical Ltd (ASX: ACW) soared today after the company released news on the upcoming study of its drug designed to treat Alzheimer’s disease. At market close, the Actinogen share price was trading at 16 cents – 19.23% hi...

Recent advances in our still-shallow understanding of the human brain have led to a renewed interest in companies that focus on neuroscience. The most famous neuroscience startup, Elon Musk’s Neuralink, is probably the first company that co...

Ask a Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In Part 2 of this edition, Anacacia Capital founder and managing director Jeremy Samuel explains how to manage ris...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

ShareCafeAlzheimer’s Decision Sends Positive Message to Aussie Biotechs The US Food and Drug Administration’s landmark but controversial approval of a new treatment for Alzheimer’s disease suggests a sea change in the regulator’s attitude t...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The CogState Limited (ASX: CGS) share price soared over 50% today after revealing some positive Japanese news. Cogstate is a neuroscience technology company that aims to optimise brain health assessments to advance the development of new me...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...